Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT04409782 |
| Other study ID # |
D20039 |
| Secondary ID |
P30CA023108-40S4 |
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
October 31, 2020 |
| Est. completion date |
November 3, 2023 |
Study information
| Verified date |
January 2024 |
| Source |
Dartmouth-Hitchcock Medical Center |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
This study investigates different ways to educate rural residents living in New Hampshire and
Vermont about cancer research studies and clinical trials to increase knowledge of, increase
positive attitudes toward, and encourage enrollment in cancer research studies and clinical
trials. The information learned from this study will contribute to a nation-wide initiative
to educate the public about clinical trials, including a nation-wide evaluation of that
initiative. The results of this study may also help researchers understand how education
about clinical trials/research affects knowledge of and attitudes toward cancer research and
clinical trials, as well as behavioral intentions and actual behaviors related to enrolling
in cancer research studies and clinical trials.
Description:
The study team will implement and evaluate the research study and clinical trials education
in two experimental arms-
1. electronic portal education about clinical trials and cancer research (Aim 1a)
2. online education via an online video about clinical trials and cancer research (Aim 1b)
The education in both formats will be based on a set of key messages that cover information
about research studies and clinical trials, including what research studies are, the
benefits, the risks, and connection to available research studies and clinical trials
Experimental Arm 1 (Aim 1a):
Implement electronic portal education regarding what clinical trials and cancer research are
and evaluate the effect on knowledge of, attitudes and behavioral intentions toward, and
actual enrollment into clinical trials and cancer research studies.
We will evaluate educational outputs from electronic portal regarding what clinical trials
and cancer research studies are. The educational content for videos was developed with the
National Cancer Institute (NCI) toolkit as a foundation, with additional content added to
adapt to our local institution, culture, and patient needs. The videos learning objectives
focus on improving participants' knowledge about what clinical trials and cancer research
studies are and how to access trials and studies, increase positive attitudes toward
participating in trials and studies, and increase their intent to enroll in trials and
studies.
Providers will receive a BPA indicating patient may qualify to participate in the education
survey. See enclosed invitation language. Providers will also have the option to include
After Visit Summary (AVS) to Patient Notes that will contain invitation link. Patients will
receive a link to the survey. If they choose to take part in the study, they will do so by
completing the online consent, eligibility screening, pre-test, and contact information
before the class they are registered for; attend the class; and complete the post-test after
the class to assess achievement of the learning objectives. They will also be asked a series
of questions to assess their eligibility for existing DCC clinical trials and research
studies.
Experimental Arm 2 (Aim 1b):
Implement online education regarding what clinical trials and cancer research are and
evaluate the effect on knowledge of, attitudes and behavioral intentions toward, and actual
enrollment into clinical trials and cancer research studies.
Participants will watch a video and view website materials ('online module') developed by DCC
using messaging provided by the National Cancer Institute (NCI) and tailored to our local
context. The online module's learning objectives will focus on improving participants'
knowledge about what clinical trials and cancer research studies are and how to access trials
and studies, increase positive attitudes toward participating in trials and studies, and
increase their intent to enroll in trials and studies. Eligible participants will complete
pre- and post- surveys to assess achievement of the learning objectives, and they will also
be asked a series of questions to assess their eligibility for existing DCC clinical trials
and research studies (see enclosed questions).
